• About
    • Viatris in Europe
      • Unlocking European patients access to medicines
    • Viatris' Manufacturing Footprint
    • Memberships and Partnerships
    • Building Sustainable Access At Scale
  • Policy
    • Policy for Access
      • Preserving Patients Access to Off-Patent Medicines
      • Protecting Access to Essential Antibiotics
      • VAM: Improving Patient Outcomes with Existing Medicines
      • Securing Access to Critical Medicines
      • Scalable European Model Tackling Antimicrobial Resistance
    • Green Deal
      • Environmental Stewardship
    • Strategic Autonomy & Industrial Strategy
      • Investing in Supply Resilience to Secure Access
      • Best Procurement Practices
    • Digital Strategy
      • European Health Data Space
  • Public Health
    • AMR
    • NCD Academy
    • Tackling Noncommunicable Diseases
    • Advancing Access to Anaphylaxis Treatment
    • Influenza
    • Infectious Diseases
    • COVID-19
  • Conversation
Show Menu

PLATINEA: A Scalable European Model Tackling Antimicrobial Resistance

In this film produced for us by BBC StoryWorks Commercial Productions, PLATINEA is a standout example of how cross-sector collaboration can help address the growing challenge of antimicrobial resistance (AMR). As a founding partner, Viatris is proud to support this Swedish platform that unites stakeholders across healthcare, academia, and public policy to safeguard antibiotic access.

AMR is projected to cause 10 million deaths per year by 2050 and add $1 trillion in global healthcare costs. Europe needs models that not only address clinical use but also builds long-term supply resilience for critical medicines.

PLATINEA is designed to do exactly that. With 21 institutional partners, the platform works to promote rational antibiotic use, while also helping health authorities secure supply through market mechanisms, like the revenue guarantee model. This film produced for us by BBC StoryWorks Commercial Productions underscores how this model can inform wider EU approaches to AMR preparedness and access.

The film includes a personal perspective from Viatris Sweden’s Medical Affairs Lead, Anne Bergman, whose story reinforces why access to effective antibiotics remains a deeply human, as well as systemic, challenge.

Viatris believes that tackling AMR requires aligned policy, investment in supply resilience, and trusted multi-stakeholder platforms. PLATINEA is one such model – and a pathway for Europe to lead by example.

Watch the full story here: Working to close the gap in antibiotic access

Leaving the Viatris site

You are now leaving the Viatris page for a Viatris affiliate site or third party site that is solely responsible for its content, including its compliance with guidelines applicable in certain geographies. Links to Viatris affiliate sites and third party sites are provided as a resource to our visitors and may not be governed by the same regulatory requirements applicable to this site and unaffiliated third party sites are subject to their own terms and data protection notices and practices. Moreover, if their third party site is subject to other country laws, regulatory requirements, data protection requirements or medical practices may differ between countries and the information provided therein may not be suitable for use in your country.

Continue
Cancel

Viatris Policy and Government Affairs

  • Privacy Notice
  • Cookie Notice
  • Terms of Use
  • Contact Us
  • Privacy Notice
    • Dutch
    • French
  • Cookie Notice
    • Dutch
    • French
  • Terms of Use
  • Contact Us
© 2025 Viatris
Created on: 6/25/2021
Updated on: 2/7/2024